Miami Cancer Institute Inaugural Skin Cancer Conference Evaluation

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree

	5	4	3	2	1
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence Not applicable|Not applicable

	5	4	3	2	1	Not applicable
Recognize high risk patients for skin cancer and appropriately referral to a dermatologist and tertiary centers with a multidisciplinary team.	Recognize high risk patients for skin cancer and appropriately referral to a dermatologist and tertiary centers with a multidisciplinary team. - 5	Recognize high risk patients for skin cancer and appropriately referral to a dermatologist and tertiary centers with a multidisciplinary team. - 4	Recognize high risk patients for skin cancer and appropriately referral to a dermatologist and tertiary centers with a multidisciplinary team. - 3	Recognize high risk patients for skin cancer and appropriately referral to a dermatologist and tertiary centers with a multidisciplinary team. - 2	Recognize high risk patients for skin cancer and appropriately referral to a dermatologist and tertiary centers with a multidisciplinary team. - 1	Recognize high risk patients for skin cancer and appropriately referral to a dermatologist and tertiary centers with a multidisciplinary team. - Not applicable
Implement management and follow up strategies for high risk patients.	Implement management and follow up strategies for high risk patients. - 5	Implement management and follow up strategies for high risk patients. - 4	Implement management and follow up strategies for high risk patients. - 3	Implement management and follow up strategies for high risk patients. - 2	Implement management and follow up strategies for high risk patients. - 1	Implement management and follow up strategies for high risk patients. - Not applicable
Discuss the latest research on new class of systemic anticancer therapies.	Discuss the latest research on new class of systemic anticancer therapies. - 5	Discuss the latest research on new class of systemic anticancer therapies. - 4	Discuss the latest research on new class of systemic anticancer therapies. - 3	Discuss the latest research on new class of systemic anticancer therapies. - 2	Discuss the latest research on new class of systemic anticancer therapies. - 1	Discuss the latest research on new class of systemic anticancer therapies. - Not applicable

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied NA= Not Applicable

	5	4	3	2	1	NA
Key Updates in Advanced Melanoma - Guilherme Rabinowits, M.D.	Key Updates in Advanced Melanoma - Guilherme Rabinowits, M.D. - 5	Key Updates in Advanced Melanoma - Guilherme Rabinowits, M.D. - 4	Key Updates in Advanced Melanoma - Guilherme Rabinowits, M.D. - 3	Key Updates in Advanced Melanoma - Guilherme Rabinowits, M.D. - 2	Key Updates in Advanced Melanoma - Guilherme Rabinowits, M.D. - 1	Key Updates in Advanced Melanoma - Guilherme Rabinowits, M.D. - NA
Challenges of SLNB for Advanced Skin Cancers in the Head and Neck Area - Geoffrey D. Young, M.D., Ph.D., FACS, FSS	Challenges of SLNB for Advanced Skin Cancers in the Head and Neck Area - Geoffrey D. Young, M.D., Ph.D., FACS, FSS - 5	Challenges of SLNB for Advanced Skin Cancers in the Head and Neck Area - Geoffrey D. Young, M.D., Ph.D., FACS, FSS - 4	Challenges of SLNB for Advanced Skin Cancers in the Head and Neck Area - Geoffrey D. Young, M.D., Ph.D., FACS, FSS - 3	Challenges of SLNB for Advanced Skin Cancers in the Head and Neck Area - Geoffrey D. Young, M.D., Ph.D., FACS, FSS - 2	Challenges of SLNB for Advanced Skin Cancers in the Head and Neck Area - Geoffrey D. Young, M.D., Ph.D., FACS, FSS - 1	Challenges of SLNB for Advanced Skin Cancers in the Head and Neck Area - Geoffrey D. Young, M.D., Ph.D., FACS, FSS - NA
Head and Neck Cancer Reconstruction - Meghan Crawley, M.D., M.S.	Head and Neck Cancer Reconstruction - Meghan Crawley, M.D., M.S. - 5	Head and Neck Cancer Reconstruction - Meghan Crawley, M.D., M.S. - 4	Head and Neck Cancer Reconstruction - Meghan Crawley, M.D., M.S. - 3	Head and Neck Cancer Reconstruction - Meghan Crawley, M.D., M.S. - 2	Head and Neck Cancer Reconstruction - Meghan Crawley, M.D., M.S. - 1	Head and Neck Cancer Reconstruction - Meghan Crawley, M.D., M.S. - NA
Is there a Role for Mohs Surgery in the treatment of Melanoma? - Michael Raisch, M.D.	Is there a Role for Mohs Surgery in the treatment of Melanoma? - Michael Raisch, M.D. - 5	Is there a Role for Mohs Surgery in the treatment of Melanoma? - Michael Raisch, M.D. - 4	Is there a Role for Mohs Surgery in the treatment of Melanoma? - Michael Raisch, M.D. - 3	Is there a Role for Mohs Surgery in the treatment of Melanoma? - Michael Raisch, M.D. - 2	Is there a Role for Mohs Surgery in the treatment of Melanoma? - Michael Raisch, M.D. - 1	Is there a Role for Mohs Surgery in the treatment of Melanoma? - Michael Raisch, M.D. - NA
New Developments in Radiation Oncology for Skin Cancers - Noah S. Kalman, M.D., MBA	New Developments in Radiation Oncology for Skin Cancers - Noah S. Kalman, M.D., MBA - 5	New Developments in Radiation Oncology for Skin Cancers - Noah S. Kalman, M.D., MBA - 4	New Developments in Radiation Oncology for Skin Cancers - Noah S. Kalman, M.D., MBA - 3	New Developments in Radiation Oncology for Skin Cancers - Noah S. Kalman, M.D., MBA - 2	New Developments in Radiation Oncology for Skin Cancers - Noah S. Kalman, M.D., MBA - 1	New Developments in Radiation Oncology for Skin Cancers - Noah S. Kalman, M.D., MBA - NA
Technical Surgical Factors that may Affect an Accurate Melanoma Staging and SLNB Results - Ramon Jimenez, M.D.	Technical Surgical Factors that may Affect an Accurate Melanoma Staging and SLNB Results - Ramon Jimenez, M.D. - 5	Technical Surgical Factors that may Affect an Accurate Melanoma Staging and SLNB Results - Ramon Jimenez, M.D. - 4	Technical Surgical Factors that may Affect an Accurate Melanoma Staging and SLNB Results - Ramon Jimenez, M.D. - 3	Technical Surgical Factors that may Affect an Accurate Melanoma Staging and SLNB Results - Ramon Jimenez, M.D. - 2	Technical Surgical Factors that may Affect an Accurate Melanoma Staging and SLNB Results - Ramon Jimenez, M.D. - 1	Technical Surgical Factors that may Affect an Accurate Melanoma Staging and SLNB Results - Ramon Jimenez, M.D. - NA
Photodynamic Therapy - Laura Benitez, APRN	Photodynamic Therapy - Laura Benitez, APRN - 5	Photodynamic Therapy - Laura Benitez, APRN - 4	Photodynamic Therapy - Laura Benitez, APRN - 3	Photodynamic Therapy - Laura Benitez, APRN - 2	Photodynamic Therapy - Laura Benitez, APRN - 1	Photodynamic Therapy - Laura Benitez, APRN - NA
Use of Total Body Mapping and Innovative Technologies for Screening and Early Detection of Melanoma - Naiara Braghiroli, M.D.	Use of Total Body Mapping and Innovative Technologies for Screening and Early Detection of Melanoma - Naiara Braghiroli, M.D. - 5	Use of Total Body Mapping and Innovative Technologies for Screening and Early Detection of Melanoma - Naiara Braghiroli, M.D. - 4	Use of Total Body Mapping and Innovative Technologies for Screening and Early Detection of Melanoma - Naiara Braghiroli, M.D. - 3	Use of Total Body Mapping and Innovative Technologies for Screening and Early Detection of Melanoma - Naiara Braghiroli, M.D. - 2	Use of Total Body Mapping and Innovative Technologies for Screening and Early Detection of Melanoma - Naiara Braghiroli, M.D. - 1	Use of Total Body Mapping and Innovative Technologies for Screening and Early Detection of Melanoma - Naiara Braghiroli, M.D. - NA

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

As a result of my participation in this Conference, I commit to make the following changes to my clinical practice: *

I will implement management and follow up strategies for high risk patients.

I will discuss the latest research on new class of systemic anticancer therapies.

I will discuss surgical aspects of skin cancer treatment.

Not applicable to my practice.

I do not agree with the recommendations presented.

I am retired.

What, if any, new skills/strategies will you apply in your clinical practice? *

What are the potential barriers or obstacles that might prevent you from implementing new strategies you learned at this activity? *

Comments

Name

Attestation *

Choose 1 option

I attest that I have participated in this live symposium in its entirety.

I attest that I have participated in _____ hours of instruction (max 2.25) during this conference.

hours attestation *

Hours attended

You are here

Miami Cancer Institute Inaugural Skin Cancer Conference Evaluation